These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7558472)

  • 1. Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users.
    Concha M; Selnes OA; McArthur JC; Nance-Sproson T; Updike ML; Royal W; Solomon L; Vlahov D
    Int J Addict; 1995 May; 30(7):823-41. PubMed ID: 7558472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological findings and psychiatric symptoms in HIV-1 infected and noninfected drug users.
    Pakesch G; Loimer N; Grünberger J; Pfersmann D; Linzmayer L; Mayerhofer S
    Psychiatry Res; 1992 Feb; 41(2):163-77. PubMed ID: 1574543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Normative data for the neuropsychological evaluation of intravenous drug users].
    Pereda M; Ayuso-Mateos JL; Gómez del Barrio A; Echevarría S; Fariñas CM; García Palomo D; González Macías J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):363-70. PubMed ID: 9972588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological and neurological manifestations of HIV-1 dementia in drug users.
    Handelsman L; Aronson M; Maurer G; Wiener J; Jacobson J; Bernstein D; Ness R; Herman S; Losonczy M; Song IS
    J Neuropsychiatry Clin Neurosci; 1992; 4(1):21-8. PubMed ID: 1627958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normative data for a brief neuropsychological screening battery. Multicenter AIDS Cohort Study.
    Selnes OA; Jacobson L; Machado AM; Becker JT; Wesch J; Miller EN; Visscher B; McArthur JC
    Percept Mot Skills; 1991 Oct; 73(2):539-50. PubMed ID: 1766784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cognition disorders in HIV infection. Validation of a brief neuropsychological evaluation battery].
    Desi M; Seibel N; Korezlioglu J; Silvestre D; Linard F
    Encephale; 1995; 21(4):289-94. PubMed ID: 7588168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the Dementia Rating Scale as a test for neuropsychological dysfunction in HIV-positive i.v. drug abusers.
    Kovner R; Lazar JW; Lesser M; Perecman E; Kaplan MH; Hainline B; Napolitano B
    J Subst Abuse Treat; 1992; 9(2):133-7. PubMed ID: 1512802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal neuropsychological evaluation of HIV-infected intravenous drug users.
    Bono G; Mauri M; Sinforiani E; Barbarini G; Minoli L; Fea M
    Addiction; 1996 Feb; 91(2):263-8. PubMed ID: 8835281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Edinburgh cohort of HIV-positive drug users: pattern of cognitive impairment in relation to progression of disease.
    Egan V; Brettle RP; Goodwin GM
    Br J Psychiatry; 1992 Oct; 161():522-31. PubMed ID: 1393340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable patterns of neuropsychological performance in HIV-1 infection.
    Dawes S; Suarez P; Casey CY; Cherner M; Marcotte TD; Letendre S; Grant I; Heaton RK;
    J Clin Exp Neuropsychol; 2008 Aug; 30(6):613-26. PubMed ID: 18608689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity.
    Concha M; Graham NM; Muñoz A; Vlahov D; Royal W; Updike M; Nance-Sproson T; Selnes OA; McArthur JC
    Am J Epidemiol; 1992 Dec; 136(11):1338-48. PubMed ID: 1362630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of HIV seropositivity and drug abuse on cognitive function.
    Grassi MP; Perin C; Clerici F; Zocchetti C; Borella M; Cargnel A; Mangoni A
    Eur Neurol; 1997; 37(1):48-52. PubMed ID: 9018033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders.
    Heaps J; Valcour V; Chalermchai T; Paul R; Rattanamanee S; Siangphoe U; Sithinamsuwan P; Chairangsaris P; Nidhinandana S; Tipsuk S; Suttichom D; Fletcher J; Shikuma C; Ananworanich J
    J Clin Exp Neuropsychol; 2013; 35(1):1-8. PubMed ID: 23113809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 associated cognitive/motor complex in an injecting drug user.
    Maxwell J; Egan V; Chiswick A; Burns S; Gordon A; Kean D; Brettle RP; Pullen I
    AIDS Care; 1991; 3(4):373-81. PubMed ID: 1786269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users (IVDUs): a follow-up study.
    Hestad K; Aukrust P; Ellertsen B; Kløve H
    J Int Neuropsychol Soc; 1996 Mar; 2(2):126-33. PubMed ID: 9375197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early neuropsychological impairment in HIV-seropositive intravenous drug users: evidence from the Italian Multicentre Neuropsychological HIV Study.
    Starace F; Baldassarre C; Biancolilli V; Fea M; Serpelloni G; Bartoli L; Maj M
    Acta Psychiatr Scand; 1998 Feb; 97(2):132-8. PubMed ID: 9517907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of neuropsychological dysfunction in the workplace: normative data from the Pittsburgh Occupational Exposures Test Battery.
    Ryan CM; Morrow LA; Bromet EJ; Parkinson DK
    J Clin Exp Neuropsychol; 1987 Dec; 9(6):665-79. PubMed ID: 3693528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed recognition memory span in HIV-1 infection.
    Martin EM; Pitrak DL; Pursell KJ; Mullane KM; Novak RM
    J Int Neuropsychol Soc; 1995 Nov; 1(6):575-80. PubMed ID: 9375245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Noopsychological changes and psychopathological characteristics of HIV-1 patients of various risk groups].
    Pakesch G; Pfersmann D; Loimer N; Grünberger J; Linzmayer L; Mayerhofer S
    Fortschr Neurol Psychiatr; 1992 Jan; 60(1):17-27. PubMed ID: 1544616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection.
    Podraza AM; Bornstein RA; Whitacre CC; Para MF; Fass RJ; Rice RR; Nasrallah HA
    J Clin Exp Neuropsychol; 1994 Oct; 16(5):777-83. PubMed ID: 7836501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.